Further evidence relating to the mode of action of nicotine in the central nervous system.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002217:Carbachol / Q000494:pharmacology*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D009538:Nicotine / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology
D001713:Biphenyl Compounds; D002800:Cholinesterase Inhibitors; D009538:Nicotine; D002217:Carbachol; D010830:Physostigmine; D000109:Acetylcholine